International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 1 , Pages 16-22, 1 May 2008

Effect of Increasing Radiation Doses on Local and Distant Failures in Patients With Localized Prostate Cancer

  • Patrick A. Kupelian, M.D.

      Affiliations

    • Department of Radiation Oncology, M.D. Anderson Cancer Center Orlando, Orlando, FL
    • Corresponding Author InformationReprint requests to: Patrick Kupelian, M.D., Department of Radiation Oncology, M.D. Anderson Cancer Center Orlando, 1400 S. Orange Ave., Orlando FL 32806. Tel: (407) 841-8666; Fax: (407) 649-6895
  • ,
  • Jay Ciezki, M.D.

      Affiliations

    • Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH
  • ,
  • Chandana A. Reddy, M.S.

      Affiliations

    • Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH
  • ,
  • Eric A. Klein, M.D.

      Affiliations

    • Glickman Urological and Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH
  • ,
  • Arul Mahadevan, M.D.

      Affiliations

    • Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH

Received 26 July 2007; received in revised form 30 August 2007; accepted 7 September 2007. published online 09 November 2007.

Purpose

To study the effect of radiation dose on local failure (LF) and distant metastasis (DM) in prostate cancer patients treated with external beam radiotherapy.

Methods and Materials

The study sample consisted of 919 Stage T1-T3N0M0 patients treated with radiotherapy alone. Three separate dose groups were analyzed: <72 Gy (n = 552, median dose, 68.4 Gy), ≥72 but <82 Gy (n = 215, median dose, 78 Gy), and ≥82 Gy (n = 152, median dose, 83 Gy). The median follow-up period for all patients and those receiving <72 Gy, ≥72 but <82 Gy, and ≥82 Gy was 97, 112, 94, and 65 months, respectively.

Results

For all patients, the LF rate at 10 and 15 years was 6% and 13%, respectively. The 7-year LF rate stratified by dose group (<72 Gy, ≥72 but <82 Gy, and ≥82 Gy) was 6%, 2%, and 2%, respectively (p = 0.012). For all patients, the DM rate at 10 and 15 years was 10% and 17%, respectively. The 7-year DM rate stratified by dose group (<72 Gy, ≥72 but <82 Gy, and ≥82 Gy) was 9%, 6%, and 1%, respectively (p = 0.008). Multivariate analysis revealed T stage (p < 0.001), pretreatment prostate-specific antigen level (p = 0.001), Gleason score (p < 0.001), and dose (p = 0.018) to be independent predictors of DM. For all 919 patients, multivariate analysis revealed only Gleason score (p = 0.009) and dose (p = 0.004) to be independent predictors of LF.

Conclusion

Although the effect of increasing radiation doses has been documented mostly for biochemical failure rates, the results of our study have shown a clear association between greater radiation doses and lower LF and DM rates.

Prostatic neoplasms, Radiotherapy, Dose, Local control, Distant metastasis

 

 Note—An online CME test for this article can be taken at http://asro.astro.org under Continuing Education.

 Conflict of interest: none.

PII: S0360-3016(07)04242-3

doi:10.1016/j.ijrobp.2007.09.020

International Journal of Radiation Oncology * Biology * Physics
Volume 71, Issue 1 , Pages 16-22, 1 May 2008